Utah · Nonprofit
Fight the New Drug Inc
Fight the New Drug Inc (Utah) receives grants from 40 organizations whose IRS filings report $2,195,731 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($780,700). 19 of them have funded it in more than one year.
- Revenue FY2025
- $902k
- Funders on record
- 40
- Grants received
- $2.2M
- Net assets
- $34k
What Fight the New Drug Inc does
Mission
Fight the New Drug is a non-religious and non-legislative organization that exists to provide individuals the opportunity to make an informed decision regarding pornography by raising awareness on its harmful effects using only science, facts, and personal accounts.
As stated on its FY2025 Form 990.
Programs
Live Presentation Program - Fight the New Drug's Live Presentation Program delivers in-person educational experiences that provide research-based information on the harms of pornography to students, parents, educators, and community groups. In 2025, the organization delivered 61 live events, reaching 15,229 individuals. Post-event survey data indicates that approximately 9495% of attendees reported increased understanding of the harms of pornography, and a majority reported feeling motivated to take action and equipped with tools to engage in informed conversations. Presentations were updated to address emerging issues such as sextortion, artificial intelligence, and digital exploitation, and were delivered across the United States and internationally.
$320,690 spent$35,218 earned by the program35% of program spendingHarms of Porn Awareness Program - Fight the New Drug's Harms of Porn Awareness Program is the organization's largest-reaching initiative, utilizing digital campaigns, social media, online resources, and documentary content to educate the public about the impacts of pornography. In 2025, the program reached over 56 million individuals across 234 countries and territories, supported by more than 6.2 million followers across platforms. Digital content generated approximately 136 million impressions, 17.4 million video views, and over 13 million engagements. The program also distributed educational materials such as the Brain, Heart, World documentary and led global campaigns like "No Porn November," which engaged tens of thousands of participants.
$432,131 spent47% of program spendingConsider Before Consuming Podcast Program - The Consider Before Consuming Podcast Program provides long-form educational content through a research-informed podcast featuring experts, survivors, and advocates discussing the personal, relational, and societal impacts of pornography. In 2025, the podcast released 25 new episodes and generated approximately 1.2 million listens during the year, contributing to over 11.3 million all-time listens. The program expanded its reach through video-first distribution and addressed timely topics such as mental health, recovery, and emerging digital platforms. This program serves as a key resource for individuals seeking deeper understanding and supports informed decision-making through evidence-based dialogue.
$162,926 spent18% of program spending
The 3 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $915,747.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2018 to 2019, from $2.1M to $867k (−59%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2020 9% · 2022 23% · 2023 4%. Grants only. Government contracts and fees sit inside program revenue.
91% of Fight the New Drug Inc’s revenue is contributions — more donation-reliant than the typical peer (82% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 7 of the last 9 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Natale McAneney
Executive Director
Board chair
Kacie Malouf
Chair
As listed on its FY2025 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 7 funders to 20 funders, grant income rose $118k → $187k.
8 of 40 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 41% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
Left out of every figure on this page: $843k from 2 payers (the payer shares this organization's board, largest PHASE Alliance). These are real filings, and they are not money Fight the New Drug Inc raised.
From the IRS filings of Fight the New Drug Inc’s funders (the co-funder graph). Top 30 of 40 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
Fight the New Drug Inc leans on a few funders — its largest provides 36% of grant income and the top three 67%; half comes from just 2 funders.
the vertical line marks half of all grant income — 2 funders to its left
42% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund Fight the New Drug Inc.
Largest funder’s share by year: 2017 42% · 2018 74% · 2019 71% · 2020 65% · 2021 90% · 2022 42% · 2023 27% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
28% of Fight the New Drug Inc's funders are still giving 3 years after their first grant; 48% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
90% of Fight the New Drug Inc's grant income comes from Utah funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $897k arriving through sponsors registered in 7 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
Fight the New Drug Inc's funding base is broadening — from 7 funders to 20 as grant income climbed.
this organization peer median middle 50% of peers· 7,883 health nonprofits $100k–$1M, FY2025
Organizations like Fight the New Drug Inc
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Utah
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
90% of spending goes to programs.
Governance
Public support
66%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Part of a family of 3 related entities
- PHASE Alliance · exempt
- Elizabeth Smart Foundation · exempt
- Malouf Foundation · exempt
Screen this organization
A dated, signed PDF of the compliance screen for Fight the New Drug Inc: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds Fight the New Drug Inc?
- Fight the New Drug Inc (Utah) receives grants from 40 organizations whose IRS filings report $2,195,731 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($780,700). 19 of them have funded it in more than one year.
- How many funders does Fight the New Drug Inc have?
- IRS filings report 40 organizations giving $2,195,731 in grants to Fight the New Drug Inc, 19 of which have funded it in more than one year.
- Who is the largest funder of Fight the New Drug Inc?
- FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $780,700 in grants. The full list of funders is on this page.
- How can an organization like Fight the New Drug Inc find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Utah. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 40 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing